160 related articles for article (PubMed ID: 25301002)
1. Serum chemokine ligand 5 (CCL5/RANTES) level might be utilized as a predictive marker of tumor behavior and disease prognosis in patients with gastric adenocarcinoma.
Sima AR; Sima HR; Rafatpanah H; Hosseinnezhad H; Ghaffarzadehgan K; Valizadeh N; Mehrabi Bahar M; Hakimi HR; Masoom A; Noorbakhsh A; Razavi Satvati N; Raziee HR
J Gastrointest Cancer; 2014 Dec; 45(4):476-80. PubMed ID: 25301002
[TBL] [Abstract][Full Text] [Related]
2. C-C motif chemokine ligand 5 (CCL5) levels in gastric cancer patient sera predict occult peritoneal metastasis and a poorer prognosis.
Wang T; Wei Y; Tian L; Song H; Ma Y; Yao Q; Feng M; Wang Y; Gao M; Xue Y
Int J Surg; 2016 Aug; 32():136-42. PubMed ID: 27398691
[TBL] [Abstract][Full Text] [Related]
3. Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma.
Boroumand-Noughabi S; Sima HR; Ghaffarzadehgan K; Jafarzadeh M; Raziee HR; Hosseinnezhad H; Moaven O; Rajabi-Mashhadi MT; Azarian AA; Mashhadinejad M; Tavakkol-Afshari J
BMC Cancer; 2010 Jun; 10():275. PubMed ID: 20534173
[TBL] [Abstract][Full Text] [Related]
4. Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination.
Sugasawa H; Ichikura T; Kinoshita M; Ono S; Majima T; Tsujimoto H; Chochi K; Hiroi S; Takayama E; Saitoh D; Seki S; Mochizuki H
Int J Cancer; 2008 Jun; 122(11):2535-41. PubMed ID: 18246596
[TBL] [Abstract][Full Text] [Related]
5. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of expression of CCL5/RANTES receptors in patients with gastric cancer.
Sugasawa H; Ichikura T; Tsujimoto H; Kinoshita M; Morita D; Ono S; Chochi K; Tsuda H; Seki S; Mochizuki H
J Surg Oncol; 2008 Apr; 97(5):445-50. PubMed ID: 18297689
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic significance of serum eotaxin-1 level in gastric cancer patients.
Koç Ü; Çetinkaya E; Bostanci EB; Kemık AS; Tez M; Gömceli İ; Akoğlu M
Dis Markers; 2013; 35(5):363-7. PubMed ID: 24223454
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer.
Kushlinskii NE; Gershtein ES; Ivannikov AA; Davydov MM; Chang VL; Ognerubov NA; Stilidi IS
Bull Exp Biol Med; 2019 Jan; 166(3):373-376. PubMed ID: 30627896
[TBL] [Abstract][Full Text] [Related]
9. CCL5 secreted by tumor associated macrophages may be a new target in treatment of gastric cancer.
Ding H; Zhao L; Dai S; Li L; Wang F; Shan B
Biomed Pharmacother; 2016 Feb; 77():142-9. PubMed ID: 26796278
[TBL] [Abstract][Full Text] [Related]
10. Serum thymidine kinase is associated with gastric adenocarcinoma.
Kemik O; Kemik AS; Purisa S; Tuzun S
Bratisl Lek Listy; 2011; 112(9):510-1. PubMed ID: 21954529
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic role of serum interleukin-18 in gastric cancer patients.
Thong-Ngam D; Tangkijvanich P; Lerknimitr R; Mahachai V; Theamboonlers A; Poovorawan Y
World J Gastroenterol; 2006 Jul; 12(28):4473-7. PubMed ID: 16874857
[TBL] [Abstract][Full Text] [Related]
12. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of serum P35 in comparison with tissue P35 in gastric adenocarcinoma and their relationship with microscopic prognostic factors.
Vahedi A; Estakhri R; Somi MH; Abdollah E; Goldust M; Samankan S
Pak J Biol Sci; 2012 Jul; 15(14):685-9. PubMed ID: 24171250
[TBL] [Abstract][Full Text] [Related]
14. Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer.
Wang TB; Deng MH; Qiu WS; Dong WG
World J Gastroenterol; 2007 Mar; 13(12):1794-7; discussion 1797-8. PubMed ID: 17465468
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor.
Kim HK; Song KS; Park YS; Kang YH; Lee YJ; Lee KR; Kim HK; Ryu KW; Bae JM; Kim S
Eur J Cancer; 2003 Jan; 39(2):184-91. PubMed ID: 12509950
[TBL] [Abstract][Full Text] [Related]
16. Enhanced serum methylated p16 DNAs is associated with the progression of gastric cancer.
Wu YC; Lv P; Han J; Yu JL; Zhu X; Hong LL; Zhu WY; Yu QM; Wang XB; Li P; Ling ZQ
Int J Clin Exp Pathol; 2014; 7(4):1553-62. PubMed ID: 24817951
[TBL] [Abstract][Full Text] [Related]
17. The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment.
Li F; Li S; Wei L; Liang X; Zhang H; Liu J
Biomarkers; 2013 Nov; 18(7):632-7. PubMed ID: 24066812
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Cannot Predict Lymph Node Metastasis and Prognosis in Patients with Early Gastric Cancer: a Single Institution Investigation in China.
Zhu GS; Tian SB; Wang H; Ma MG; Liu Y; Du HS; Long YP
Curr Med Sci; 2018 Feb; 38(1):78-84. PubMed ID: 30074155
[TBL] [Abstract][Full Text] [Related]
19. Serum carcinoembryonic antigen as a prognostic factor in resectable gastric cancer.
Tachibana M; Takemoto Y; Nakashima Y; Kinugasa S; Kotoh T; Dhar DK; Kohno H; Nagasue N
J Am Coll Surg; 1998 Jul; 187(1):64-8. PubMed ID: 9660027
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y
World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
